Johnny Huard

This inventor holds 19 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Stem Cell Research. Top assignees: University of Pittsburgh, Other. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johnny Huard. Retrieved from https://idiyas.com/inventor/johnny-huard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 16)

% Patents Active = 47.4

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 149(Granted Patents)

Location History:

Pittsburgh, PA (US) (2006 - 2015)
Wexford, PA (US) (2005 - 2016)
Waxford, PA (US) (2015 - 2017)
Houston, TX (US) (2017 - 2019)

Company Filing History:

17 out of 1,963

University of Pittsburgh

patents

2 out of 834,601

Other

patents

Years Active: 2005-2019

Loading Chart...

Areas of Expertise:

Stem Cell Function

Muscle-Derived Cells

Tissue Repair

Bone Augmentation

Progenitor Cells

Nerve Regeneration

Matrix Preparation

Urinary Tract Treatment

Soft Tissue Augmentation

Organ Repair

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10293001 - Compositions and methods for restoring or rejuvenating stem/progenitor cell function (2019-05-21),

2. 9744267 - Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair (2017-08-29),

3. 9617516 - Muscle-derived cells (MDCs) for promoting and enhancing nerve repair and regeneration (2017-04-11),

4. 9410124 - Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof (2016-08-09),

5. 9352004 - Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction (2016-05-31),

6. 9295696 - Compositions and methods for restoring or rejuvenating stem/progenitor cell function (2016-03-29),

7. 9199003 - Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof (2015-12-01),

8. 8986671 - Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof (2015-03-24),

9. 8961954 - Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same (2015-02-24),

10. 8790680 - Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair (2014-07-29),

11. 8765120 - Muscle-derived cells (MDCS) for augmenting or bulking urethral sphincter-muscle tissue (2014-07-01),

12. 8741277 - Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof (2014-06-03),

13. 8685385 - Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof (2014-04-01),

14. 8580561 - Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof (2013-11-12),

15. 8105834 - Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using same (2012-01-31),

Title: **Johnny Huard: Innovator in Stem Cell Technologies**

Introduction

Johnny Huard is a prominent inventor based in Wexford, PA, known for his groundbreaking work in stem cell research. With a remarkable portfolio of 19 patents, Huard has made significant contributions to the field of regenerative medicine, focusing on innovative methods and compositions involving stem and progenitor cells.

Latest Patents

Among his latest patents, Huard has developed compositions and methods aimed at restoring or rejuvenating stem/progenitor cell function. This invention utilizes autologous stem/progenitor cells to enhance adult stem cell function in mammals, ultimately extending lifespan and improving health. Additionally, it encompasses compositions containing regulatory factors secreted from isolated mammalian stem cells, promoting health and longevity in mammals.

Another noteworthy patent involves the rapid preparation of stem cell matrices for tissue and organ treatment. This invention details a swift method for generating stem cell and physiologically acceptable matrices that do not require extensive pre-use cultivation. The stem cell-matrix compositions offer immediate utility for practitioners, allowing for quick preparation before application, thus optimizing the healing process.

Career Highlights

Huard's career has been marked by his association with the University of Pittsburgh, where he has contributed his expertise in stem cell technology and regenerative medicine. His inventive approaches and pioneering research have positioned him as a key figure in the advancement of these critical areas.

Collaborations

Throughout his career, Huard has collaborated with esteemed professionals in the field, including Michael B. Chancellor and Christopher C. Capelli. These collaborations have fostered an environment of innovation and progress within stem cell research.

Conclusion

Johnny Huard's dedication to innovation in stem cell technologies reflects his commitment to enhancing health outcomes through scientific advancement. His patent portfolio not only showcases his ingenuity but also promises to impact the future of medical treatments and regenerative therapies significantly.

Profile summary based on public USPTO records.